By: Bruce Goldman Source: Stanford Medicine News Center Stanford scientists created an odd couple: a modified version of an immune-signaling protein and a coordinately modified receptor for this protein. The two bind only to each other, easing an advanced anti-cancer therapy’s side effects. Altering a powerful immune-signaling chemical plus its receptor on immune cells may bring a promising cancer treatment …